Inventor · disambiguated record
Dimitra Louka
Also filed as: LOUKA DIMITRA
6 granted patents·7 pending applications·15 citations·filing 2019–2024
80Inventor score
Files withRIPPLE THERAPEUTICS CORP13
Top patents by PatentIndex Score
13 records- 0193US10588862B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 17, 2020·5 cites·50 claims
- 0292US10959954B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 30, 2021·3 cites·19 claims
- 0392US10945958B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 16, 2021·3 cites·19 claims
- 0492US10632075B2Glass formulations and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Apr 28, 2020·4 cites·29 claims
- 0585US2025049719A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 0681US2023225975A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 0775US11612567B2Ocular inserts comprising a covalently linked steroid dimerRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 28, 2023·0 cites·15 claims
- 0875US2025065053A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 0972US2021205222A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1068US2023113525A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1161US11464914B2Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2020·Granted Oct 11, 2022·0 cites·20 claims
- 1261US2022387213A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 1348US2022288277A1Surface coatings and implantable devices comprising dimeric steroid prodrugs, and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dimitra Louka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →